Corza Medical Named “Best Overall MedTech Company” in 8th Annual MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies
WESTWOOD, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Corza Medical today announced that it has been selected as the winner of the “Best Overall MedTech Company” award in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market.
Corza Medical provides healthcare professionals with a platform of surgical technologies and features industry-leading brands. The company partners closely with clinicians and surgical providers to create a differentiated surgical experience through remarkable products and services that save time, money, and effort. Working with diverse healthcare providers ranging from hospital administrators to private practices, this exceptional medical device company is relentlessly focused on delivering products and services that are customer-centric and consistently perform to surgeons' exact needs when treating their patients.
Corza Medical’s three major global business units enable technologies across a spectrum of health: Biosurgery, Wound Closure, and Ophthalmology. The Corza Medical Biosurgery unit provides best-in-class, innovative technology that helps control bleeding during surgery. The Wound Closure unit offers industry-leading needle technology that pairs with advanced traditional and barbed sutures to deliver wound‑closure capabilities. Lastly, the Ophthalmology unit focuses on improving care through high-performance instrumentation, surgical lenses, and other innovative technologies.
“We believe it takes a three-pronged approach: digitally surround the customer, be responsive and agile to customer needs, and provide a steady stream of needed technologies and services to facilitate the uninterrupted pursuit of their patient-care missions. Our trusted family of products is the result of listening to and collaborating with surgeons across specialties to gain a better understanding of what they need,” said Tom Testa, CEO of Corza Medical. “This is an incredible accolade from MedTech Breakthrough and validates our mission in working closely with surgeons and other customers as we develop innovative solutions that address their specific challenges to better serve their patients.”
The mission of the MedTech Breakthrough Awards is to honor excellence and recognize innovation, hard work, and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and many more. This year’s program attracted thousands of nominations from over 18 different countries throughout the world.
“Many companies shift their focus away from service and customer partnerships towards their latest innovations, resulting in a gap for partnerships involving essential surgical technologies,” said Steve Johansson, managing director, MedTech Breakthrough. “Corza Medical is our “MedTech Company of the Year” for its high-performance technologies and its focus on customer service. By doing the critical little things right every day and every time, they deliver a differentiated experience and outstanding value to their customers globally. We are thrilled to recognize the entire Corza Medical team for a well-deserved 2024 MedTech Breakthrough Award win.”
The Company continues to make investments in a robust and differentiated digital ecosystem to be agile and effective when supporting customers. By acquiring key suppliers and manufacturing facilities globally, Corza also integrates its manufacturing and supply chain vertically. Technology and innovation centers have also been established to foster closer customer partnerships. Surgeons can collaborate with product engineers in medical‑procedure simulations, “test driving” products and providing feedback that benefits product development and refinement.
About Corza Medical
Corza Medical is a leading global manufacturer of innovative surgical technologies. With a global team of over 3,000 employees supporting clinicians, distributor-partners, and medical device companies worldwide, Corza provides healthcare professionals a platform of surgical technologies with many industry-leading brands, including Quill® barbed sutures, Sharpoint® Plus and Look™ surgical sutures, Katena® reusable and Blink™ single-use ophthalmic instruments, Barron corneal transplant devices, Sharpoint® microsurgical knives, and the TachoSil® fibrin sealant patch. For more information, please visit www.corza.com.
About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.
Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
Media Contact
Arun Mohan—VP, Marketing, Communications and Strategy
media@corza.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/13d07687-d249-4564-828b-c95bcb548d65
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Ageas and Taiping deepen cooperation in pension solutions20.5.2024 13:00:00 CEST | Press release
Ageas and Taiping deepen cooperation in pension solutions Ageas announces today that following confirmation of its participation in the capital increase tender in November 2023, an agreement has been concluded with China Taiping Insurance Holdings (CTIH) to subscribe to the capital increase of its wholly controlled subsidiary Taiping Pension Co., Ltd (“TPP”) for a total consideration of RMB 1,075 million (around EUR 137 million)*. After closing of the transaction Ageas will hold 10% of the enlarged share capital of TPP. The investment in TPP will allow Ageas to tap into the significant growth potential of the Chinese pension market, capitalising on the increasing demand for personal pension products in China. It also helps Ageas to strengthen its presence in the largest growth market in Asia, diversify its business offerings, and consolidate its long-standing strategic partnership with China Taiping. Established in 2004 and headquartered in Shanghai, TPP is one of the largest pension i
Bayport Management Ltd announces standstill agreement and is in constructive negotiations with creditors to address its capital structure, cash interest obligations and debt maturities20.5.2024 12:47:58 CEST | Press release
Bayport Management Ltd announces standstill agreement and is in constructove negotiations with creditiors to address its capital structure, cash interest obligations and debt maturities Attachments Bayport Management Limited - Market Announcement - 20 May 2024Bayport Management Limited - Market Announcement - 20 May 2024
The Board of Directors of Eezy Plc has resolved to change the target levels of the performance criteria for the fourth performance period of the share-based incentive plan for the company's key employees20.5.2024 12:30:00 CEST | Press release
EEZY PLC -- STOCK EXCHANGE RELEASE – 20 MAY 2024 AT 13:30 PM The Board of Directors of Eezy Plc has resolved to change the target levels of the performance criteria for the fourth performance period of the share-based incentive plan for the company's key employees Eezy Plc has on 15 March 2023 published information on the fourth earning period of the long-term incentive plan for the key employees of the company. The earning period is 24 months, starting on 1 January 2023, and ending on 31 December 2024. The reward criteria for the fourth earning period are based on Eezy Plc’s total shareholder return, operating profit percent and an ESG component. The Board of Directors of Eezy Plc has today resolved to change the target levels of the rewards criteria for total shareholder return and revenue percentage in accordance with the terms and conditions of the long-term incentive plan. A maximum of 256,000 reward shares could be awarded for the fourth earning period, and the maximum dilution w
International Tea Culture Festival Held in Chaoyang, Beijing20.5.2024 11:23:13 CEST | Press release
BEIJING, May 20, 2024 (GLOBE NEWSWIRE) -- The 2024 Beijing Chaoyang International Tea Culture Festival kicked off recently at the Chaoyang Park and the Junwangfu Hotel, gathering more than 100 tea brands for tea party, tea-related poem recitals and traditional Chinese-style performances, attracting many guests from both home and abroad. A Media Snippet accompanying this announcement is available by clicking on this link. Upon entering the Junwangfu Hotel, one can hear the melodious sound of the guqin from afar. This quaint garden-style building has been transformed into a tea culture reception hall with four distinctive areas for exhibition and display, interactive experience, immersive shopping, and new cultural experience, respectively, providing visitors with immersive tours featuring the traditional Chinese tea culture. There were also special activities such as incense rituals, ikebana, Hanfu performances, tea-related poems, tasting tea and identifying flowers, as well as new cons
Start of construction work on the Uus-Kindrali20.5.2024 09:52:00 CEST | Press release
Start of construction work on the Uus-Kindrali Pro Kapital has started the construction of the next phase of the Kindrali Houses project in Tallinn Kristiine City. The building at Talli 3/Sammu 8, which is part of the Uus-Kindrali project, will comprise 90 apartments and one commercial unit. The new phase of Kindrali Houses will consist of a 7-storey building with 1-5 bedroom apartments. To date, 31% of the apartments have already been pre-sold, which was the incentive to start construction work. Uus-Kindrali, with its modern and Scandinavian architecture, will be built in Kristiine City and will be framed by a tree-lined avenue and Brooklyn-style high ground floor homes and commercial space opening directly onto the street. On the other side, between the buildings is a spacious and private courtyard with fruit trees, berry bushes, cozy seating and play areas, offering joy and activity for everyone. The architects of the buildings and landscape of the Uus-Kindrali is Allianss Arhitekti